Cryofocus Medtech (Shanghai) (6922 HK)

Cryofocus Medtech (Shanghai) specializes in the research, development, manufacturing, and sale of minimally invasive interventional medical devices, primarily utilizing cryoablation technology. The company's product portfolio addresses vascular interventional therapy for cardiovascular diseases such as atrial fibrillation and hypertension, as well as natural orifice transluminal endoscopic surgery for urinary, respiratory, and digestive diseases including bladder cancer and gastric cancer. Headquartered in Shanghai, China, the company was founded in 2013.